Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models-Reference-Cited by-同舟云学术

Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models

Published:2015-01 Issue:2 Volume:356 Page:443-453
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zi Fu-Ming,He Jing-Song,Li Yi,Wu Cai,Yang Li,Yang Yang,Wang Li-Juan,He Dong-Hua,Zhao Yi,Wu Wen-Jun,Zheng Gao-Feng,Han Xiao-Yan,Huang He,Yi Qing,Cai Zhen

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

2. Global cancer statistics;Jemal;CA Cancer J. Clin,2011

3. Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group;Ludwig;Blood,2008

4. Repurposing Approved and Abandoned Drugs for the Treatment and Prevention of Cancer through Public–Private Partnership;Weir;Cancer Res,2012

5. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women;Hu;J. Natl. Cancer Inst,1999

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin and risk of hematological cancers in patients with diabetes: a systematic review and meta-analysis;Annals of Saudi Medicine;2024-03

2. Metformin and chidamide synergistically suppress multiple myeloma progression and enhance lenalidomide/bortezomib sensitivity;Environmental Toxicology;2024-01-22

3. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer;Drug Repurposing;2024

4. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors;Frontiers in Oncology;2023-11-20

5. Metformin restrains ZIKV replication and alleviates virus-induced inflammatory responses in microglia;International Immunopharmacology;2023-08